Bamforth–Lazarus Syndrome

Bamforth–Lazarus syndrome is a very rare genetic condition. Babies are born with congenital hypothyroidism (the thyroid gland does not work or is missing), and they often have a cleft palate and spiky/scanty hair. Some babies also have choanal atresia (blocked back of the nose) or a bifid epiglottis (split flap above the voice box). The main reason is a harmful change (mutation) in a gene called FOXE1. This gene is important for building the thyroid and the palate while the baby is growing in the womb. Early treatment is important because the thyroid hormone supports brain growth. GARD Information Center+2Orpha+2

Bamforth–Lazarus syndrome is a genetic condition where a baby is born without a working thyroid gland (often completely missing) and with mouth and airway differences, especially a cleft palate. Because the thyroid does not make hormone, the baby has congenital hypothyroidism. Without prompt treatment, low thyroid hormone can harm brain development and growth. The cause is a harmful change in the FOXE1 gene, which normally tells the embryo how to form the thyroid, palate, and some airway parts. The condition is rare worldwide. Doctors diagnose it by newborn screening (high TSH, low T4), by finding the thyroid is absent or very small on imaging, by seeing the cleft palate, and by genetic testing. Treatment is levothyroxine every day by mouth, plus surgical repair of the cleft palate when the child is ready. With early, steady hormone therapy and good team care, most children can grow well and learn well. GARD Information Center+2Orpha+2

Bamforth–Lazarus syndrome is inherited in an autosomal recessive way. That means a child becomes affected when they receive one faulty FOXE1 gene from each parent. Parents are usually healthy “carriers.” Genetic testing can confirm the diagnosis and can help a family understand future pregnancy risks. NCBI

Bamforth–Lazarus syndrome is a very rare genetic condition present from birth. Babies with this syndrome usually have congenital hypothyroidism (the thyroid gland is missing, small, or in the wrong place and cannot make enough hormone). Many also have cleft palate (an opening in the roof of the mouth), sometimes blocked back parts of the nose (choanal atresia), and a typical spiky or coarse hair appearance. A few may have a bifid epiglottis (the little “lid” in the throat is split). The thyroid problem is the main medical issue and needs early treatment to protect brain growth and overall development. This syndrome is caused by harmful changes in a single gene called FOXE1, also known as TTF-2. It is inherited in an autosomal recessive way, which means a child gets one nonworking copy of the gene from each parent. search.thegencc.org+3NCBI+3Orpha+3

Other names

This condition can also be called:

• Bamforth–Lazarus syndrome (BAMLAZ)

• FOXE1-related syndromic congenital hypothyroidism

• TTF-2 deficiency
  All these names refer to the same rare disorder linked to changes in the FOXE1 gene. NCBI+1

Types

Doctors do not divide Bamforth–Lazarus syndrome into strict official subtypes, but it helps to think of clinical patterns based on what is seen in each child:

1. Thyroid-only prominent type. Severe congenital hypothyroidism due to thyroid agenesis, hypoplasia, or ectopic thyroid, with minimal airway or palate findings. NCBI+1

2. Palate–airway type. Cleft palate with or without choanal atresia, feeding and breathing trouble, plus congenital hypothyroidism. Orpha+1

3. Laryngeal type. Hypothyroidism with bifid epiglottis or other laryngeal differences causing stridor or hoarseness. GARD Information Center

4. Hair-skin noticeable type. Same thyroid problem, but the spiky/coarse hair is a striking feature for the family and doctors. Orpha

These “types” overlap. One child may show features from more than one group, because all are expressions of the same FOXE1-related condition.

Causes

Core cause:

1. Biallelic FOXE1 gene variants. The single, proven root cause is having two harmful changes in the FOXE1 (TTF-2) gene—one from each parent. FOXE1 is a transcription factor needed for thyroid formation and face/nose/throat development. When both copies fail, the thyroid and palate/airway may not form normally. Frontiers+1

Ways the gene can be damaged (molecular “causes”):

1. Frameshift variants that change the reading frame and produce a nonfunctional protein. PubMed
2. Nonsense variants that introduce an early “stop” and truncate the FOXE1 protein. Karger Publishers
3. Missense variants that swap one amino acid for another and disturb DNA binding or protein stability (for example, the R73S change reported in patients). PubMed
4. Splice-site variants that prevent proper processing of FOXE1 RNA. Karger Publishers
5. Small deletions/insertions within FOXE1 that disrupt normal function. Karger Publishers
6. Larger gene deletions or structural changes that remove FOXE1 or its regulatory regions. panelapp.genomicsengland.co.uk

Developmental pathways (how gene damage leads to features):

1. Failed thyroid bud growth/migration, leading to thyroid agenesis, hypoplasia, or ectopic thyroid tissue. Frontiers
2. Abnormal fusion of palatal shelves, resulting in cleft palate. Frontiers
3. Choanal formation defects, causing choanal atresia or stenosis. ScienceDirect
4. Laryngeal patterning defects such as bifid epiglottis. GARD Information Center
5. Hair follicle differentiation effects, explaining the characteristic spiky hair. Orpha

Why the same gene change can look different in different people (modifiers):

1. Modifier genes (other genes that slightly change palate, airway, or thyroid development) can raise or lower severity. (This is a general principle in rare genetic syndromes.) Karger Publishers
2. FOXE1 poly-alanine tract length—a normal, variable stretch in the protein—may influence thyroid development risk and expressivity in some families. Evidence is mixed. Frontiers
   15) Regulatory region variants near FOXE1 that reduce gene expression can mimic coding mutations. Karger Publishers
3. Compound heterozygosity (two different FOXE1 variants in the same person) can produce the syndrome. Karger Publishers
4. Consanguinity (parents related by blood) raises the chance both carry the same rare FOXE1 variant and a child inherits two copies. (General genetics principle.) NCBI
   18) Stochastic (random developmental) factors during early embryo growth can sway palate and airway outcomes even with the same genotype. (General principle supported by variable expressivity.) Karger Publishers
5. Delayed diagnosis and untreated hypothyroidism do not cause the syndrome, but they worsen outcomes (growth and neurodevelopment), making the condition appear more severe. AccessPediatrics
6. Environmental influences on thyroid hormone needs (for example, severe iodine lack) do not cause Bamforth–Lazarus syndrome, but can aggravate hypothyroidism once it is present. (Endocrine principle.) ScienceDirect

Symptoms and signs

1. Lack of thyroid hormone at birth (congenital hypothyroidism). Babies may be sleepy, feed poorly, or have constipation if not picked up by newborn screening. NCBI

2. Cleft palate. An opening in the roof of the mouth can cause nasal speech, milk regurgitation into the nose, and feeding problems. Orpha

3. Choanal atresia or narrowing. Blocked back of the nose leads to noisy breathing, cyanosis when feeding, and breathing relief when crying. AccessPediatrics

4. Spiky/coarse hair. Hair looks stiff or stands up; it is a characteristic clue for this syndrome. Orpha

5. Bifid epiglottis or other laryngeal differences. This may cause stridor, choking, or an unusual cry. GARD Information Center

6. Feeding difficulties. Because of cleft palate and airway issues, babies may need special bottles or feeding strategies. Orpha

7. Breathing trouble in the newborn period. Choanal atresia or laryngeal anomalies can cause distress and need urgent evaluation. AccessPediatrics

8. Prolonged jaundice, puffy face, or large tongue (macroglossia) from untreated hypothyroidism. NCBI

9. Poor growth if hypothyroidism is not treated early and well. NCBI

10. Developmental delay when thyroid hormone treatment is late or inadequate; early treatment usually protects development. Access Anesthesiology

11. Hoarse voice due to laryngeal differences or hypothyroidism effects on the voice. GARD Information Center

12. Facial differences (described in some patients), such as coarse features; the range is wide. MalaCards

13. Recurrent ear or respiratory infections related to palate/airway anatomy and feeding/aspiration risks. (Clinical experience in cleft/airway care.) AccessPediatrics

14. Cold intolerance, dry skin, or constipation are typical hypothyroid symptoms if dosing is not optimal. NCBI

15. Rare brain imaging findings such as porencephaly have been reported in isolated cases, but are not common. GARD Information Center

Diagnostic tests

A) Physical examination (bedside observations)

1. Full newborn exam focused on thyroid signs (lethargy, hypotonia, prolonged jaundice) and general growth. This sets the first clinical suspicion. NCBI

2. Orofacial inspection to look for cleft palate or submucous cleft that may be subtle. Orpha

3. Nasal patency check (e.g., passing a soft catheter) to screen for choanal atresia. AccessPediatrics

4. Hair and skin look/feel to note the characteristic spiky hair and any dry skin from hypothyroidism. Orpha

5. Laryngeal observation (at bedside if symptomatic) for stridor or hoarseness that suggests epiglottic anomalies. GARD Information Center

B) Manual or simple bedside tests

6. Suck and swallow assessment by a trained clinician to evaluate feeding safety in babies with cleft palate. Orpha

7. Mirror fog test or cold metal spatula under the nose to see airflow reduction from choanal blockage. AccessPediatrics

8. Pulse oximetry trend during feeds and sleep to screen for hypoxemia from airway obstruction. (Common pediatric practice.) AccessPediatrics

9. Bedside flexible nasopharyngoscopy (quick endoscopic look) when trained teams are available to inspect choanae and palate motion. AccessPediatrics

10. Feeding evaluation with thickened fluids or special bottles to test practical strategies and reduce aspiration risk. AccessPediatrics

C) Laboratory and pathological tests

11. Newborn screening (heel-prick) for high TSH and/or low T4, which usually flags the condition within days of birth; confirmatory blood tests follow. NCBI

12. Serum TSH and free T4 to confirm congenital hypothyroidism and guide levothyroxine dosing over time. NCBI

13. Serum thyroglobulin to help distinguish thyroid agenesis (often very low) from ectopic or small thyroid tissue (can be measurable). panelapp.genomicsengland.co.uk

14. Molecular genetic testing of the FOXE1 gene (sequencing and deletion/duplication analysis) to confirm the diagnosis and enable family counseling. Clinical labs and registries list available tests. NCBI

15. Targeted gene panels for congenital hypothyroidism (include FOXE1 and other genes) when the presentation suggests a syndromic form. panelapp.genomicsengland.co.uk

D) Electrodiagnostic / physiologic studies

16. Polysomnography (sleep study) if airway obstruction or apneas are suspected from choanal atresia or laryngeal anomalies. (Airway evaluation standard.) AccessPediatrics

17. Auditory brainstem response (ABR) when recurrent ear problems or cleft-related middle-ear fluid raise concern; ABR is an electrophysiologic hearing test used in infants. (Cleft-care practice.) AccessPediatrics

18. Electrocardiogram (ECG) if severe hypothyroidism with bradycardia or pericardial effusion is suspected; supports safe management. (Endocrine practice.) NCBI

E) Imaging and endoscopic tests

19. Thyroid ultrasound to look for agenesis, hypoplasia, or ectopic thyroid; painless and first-line. panelapp.genomicsengland.co.uk

20. Thyroid scintigraphy (e.g., technetium-99m pertechnetate) to confirm absent or ectopic thyroid tissue. CT/MRI of the skull base and nose and nasal endoscopy to define choanal atresia; laryngoscopy to visualize a bifid epiglottis when symptoms suggest it. AccessPediatrics+1

Non-pharmacological treatments (therapies and other supports)

Below are supportive, non-drug therapies that help children with Bamforth–Lazarus syndrome. Each item lists a 150-word description, then purpose, then mechanism in simple terms.

1) Newborn screening follow-through and urgent endocrinology visit

Description (≈150 words): When newborn screening shows high TSH or low T4, the baby should be seen urgently. In Bamforth–Lazarus syndrome, the thyroid is absent or tiny, so the child needs thyroid hormone right away. Fast action in the first days of life protects the brain. Parents should keep the first endocrinology appointment, bring screening results, and start medication immediately if prescribed. Ongoing visits check growth, head size, feeding, sleep, and development. This early step prevents long-term disability that can occur if treatment is delayed. The team also arranges imaging (to look for the thyroid), a hearing check if needed, and plans for cleft palate care. The clinic teaches safe handling of the medicine and how to give it correctly. PMC+1
Purpose: Prevent brain injury from low thyroid and start lifelong care early. PMC
Mechanism: Rapid identification and intervention restore normal blood T4 early in life. PMC

2) Multidisciplinary cleft team care

Description: Children with a cleft palate do best when a team manages surgery, feeding, speech, hearing, and dental needs together. The team typically includes a plastic surgeon, ENT, speech-language pathologist, audiologist, pediatrician, endocrinologist, and dentist/orthodontist. Coordinated planning schedules the best time for palate repair, helps with ear fluid problems, and supports speech development. Regular team visits track progress. GARD Information Center
Purpose: Combine all expertise to improve feeding, speech, hearing, and growth. GARD Information Center
Mechanism: Integrated care closes the palate gap, directs therapy, and reduces complications. GARD Information Center

3) Feeding support and safe swallowing strategies

Description: A cleft palate can make feeding hard. Special bottles, nipples, and positions improve milk flow and reduce choking and nasal regurgitation. Lactation support can help mothers maintain milk supply and learn techniques that work with a cleft. Growth is tracked closely using weight and length charts. If intake remains low, the team may consider temporary tube feeding until after palate repair. Nutrition counseling ensures adequate calories and micronutrients. GARD Information Center
Purpose: Ensure safe feeding and normal weight gain before and after surgery. GARD Information Center
Mechanism: Adaptive equipment and posture reduce leakage into the nose and improve swallow. GARD Information Center

4) Early Intervention (developmental therapies)

Description: Babies with congenital hypothyroidism who are well treated usually develop normally, but some children with a cleft palate or airway issues may need extra help. Early Intervention provides physical therapy, occupational therapy, and developmental teaching in the home or clinic. Therapists coach parents on play, fine motor skills, and communication milestones. Starting before delays appear builds strong foundations for later learning. PMC
Purpose: Optimize motor, cognitive, and communication development. PMC
Mechanism: Frequent, play-based practice strengthens neural pathways during brain growth. PMC

5) Speech-language therapy (including resonance therapy)

Description: A cleft palate can cause hypernasal speech and articulation problems. After surgical repair, speech therapy helps correct sound production and resonance. Therapy may start early, focusing on pre-speech skills and feeding-related oral motor work. It continues after surgery to build clear speech. Parents learn exercises to practice at home. GARD Information Center
Purpose: Improve intelligibility and reduce nasal air escape during speech. GARD Information Center
Mechanism: Guided practice reshapes motor patterns for accurate articulation and velopharyngeal closure. GARD Information Center

6) ENT assessment and airway management

Description: Some children with BAMLAZ have choanal atresia or a bifid epiglottis. ENT specialists assess breathing, snoring, feeding-related choking, and ear fluid problems. They plan monitoring, imaging, and, if needed, procedures for nasal blockage or airway support. Regular hearing checks are also important because middle ear fluid is common with cleft palate. GARD Information Center
Purpose: Keep the airway safe and support hearing and speech. GARD Information Center
Mechanism: Structural assessment plus targeted procedures reduce obstruction and ear complications. GARD Information Center

7) Genetic counseling for the family

Description: A genetics professional explains how BAMLAZ happens, the autosomal recessive inheritance pattern, and the chance of recurrence in future pregnancies. They discuss carrier testing of parents and sometimes relatives, and options for prenatal or preimplantation testing in the future. Counseling also provides emotional support and links to resources for rare diseases. NCBI
Purpose: Help families understand risks, plan future pregnancies, and connect to support. NCBI
Mechanism: Education plus testing reveals carrier status and informs reproductive choices. NCBI

8) Imaging to define thyroid anatomy

Description: Ultrasound or nuclear medicine scans can look for the thyroid gland and show if it is missing or in an unusual place. Knowing the anatomy confirms dysgenesis (the most common cause in BAMLAZ) and supports the final diagnosis. Imaging is done alongside blood tests, not instead of them, and does not delay starting hormone therapy. PMC
Purpose: Document thyroid absence or abnormal position to support the diagnosis. PMC
Mechanism: Imaging reveals structural causes of hypothyroidism while labs show hormone levels. PMC

9) Growth and neurodevelopmental monitoring

Description: The clinical team plots weight, length, and head size and tracks milestones. If levothyroxine dosing is correct, growth and development should follow normal curves. If growth slows or milestones lag, dosing, absorption, or adherence need review. PMC
Purpose: Ensure normal growth and learning with timely dose adjustments. PMC
Mechanism: Regular checks detect problems early so thyroid hormone levels can be optimized. PMC

10) Medication administration coaching

Description: Levothyroxine should be given on an empty stomach, crushed (if a tablet) and mixed with a small amount of water or breast milk—not with soy formula, iron, or calcium at the same time because these can block absorption. Caregivers learn to give the dose at the same time daily and to separate it from interfering feeds or supplements. FDA Access Data
Purpose: Maximize absorption and keep thyroid levels steady. FDA Access Data
Mechanism: Spacing from binding agents prevents reduced bioavailability of levothyroxine. FDA Access Data

11) Hearing evaluation and early treatment of ear disease

Description: Fluid behind the eardrum is common with cleft palate and can reduce hearing, which then affects speech development. Regular hearing checks allow early treatment or tubes if needed. GARD Information Center
Purpose: Preserve hearing to support speech and learning. GARD Information Center
Mechanism: Timely detection and ENT care prevent long-term hearing loss from middle ear fluid. GARD Information Center

12) Dental/orthodontic follow-up

Description: Children with a cleft may have dental crowding, bite issues, or missing teeth. Regular dental care and planning for orthodontics in later childhood lead to better chewing, appearance, and speech. GARD Information Center
Purpose: Maintain oral health and plan for future alignment and function. GARD Information Center
Mechanism: Preventive care and staged orthodontics correct growth-related dental issues. GARD Information Center

13) Psychosocial support and parent education

Description: Caring for a child with a rare disease can be stressful. Counseling, peer groups, and educational sessions reduce anxiety and help families stay on track with daily medication and appointments. GARD Information Center
Purpose: Build confidence and resilience for long-term care. GARD Information Center
Mechanism: Supportive counseling improves adherence and family well-being. GARD Information Center

14) Safe sleep and airway positioning guidance

Description: Babies with nasal blockage or airway differences may sleep better with careful positioning and monitoring. Parents learn to watch for noisy breathing, pauses, and poor feeding that might signal obstruction and to seek ENT review promptly. GARD Information Center
Purpose: Reduce airway risk and improve rest and feeding. GARD Information Center
Mechanism: Positioning and early ENT input keep the airway stable. GARD Information Center

15) Surgical timing counseling for palatoplasty

Description: The team explains when the palate repair will happen (often in the first year of life) and how to prepare. They discuss feeding changes, pain control, and the plan for speech therapy afterward. GARD Information Center
Purpose: Set expectations and improve recovery. GARD Information Center
Mechanism: Clear education supports adherence to pre- and post-operative plans. GARD Information Center

16) Vaccination on schedule

Description: Children with BAMLAZ should follow the routine immunization schedule unless the doctor advises otherwise. Good general health supports normal growth and reduces infections that can interrupt feeding and therapy. GARD Information Center
Purpose: Prevent common illnesses that could complicate care. GARD Information Center
Mechanism: Immunity reduces disease burden and hospital visits. GARD Information Center

17) Nutrition counseling around levothyroxine–food interactions

Description: Families learn that some foods and supplements (iron, calcium, soy) can reduce levothyroxine absorption if taken together. A nutritionist helps fit the daily dose into the family’s routine with proper spacing from these items. FDA Access Data
Purpose: Avoid low thyroid levels caused by blocked absorption. FDA Access Data
Mechanism: Practical meal planning keeps hormone levels steady. FDA Access Data

18) Oral hygiene and speech-friendly habits after repair

Description: After palate repair, gentle oral hygiene, avoiding hard objects in the mouth, and following speech therapy advice help the palate heal and speech improve. GARD Information Center
Purpose: Protect the surgical repair and support clear speech. GARD Information Center
Mechanism: Good habits prevent breakdown of the repair and promote therapy success. GARD Information Center

19) School-age learning support

Description: With good thyroid control, children usually learn normally. If school difficulties appear, teachers and therapists can build a plan (extra reading help, speech sessions, or classroom supports). PMC
Purpose: Maintain steady progress in reading, language, and motor skills. PMC
Mechanism: Targeted educational supports close skill gaps early. PMC

20) Family planning and future pregnancy guidance

Description: Because BAMLAZ is autosomal recessive, each future pregnancy has a 25% chance to be affected if both parents are carriers. Genetic counseling discusses prenatal testing options and the importance of maternal iodine sufficiency in pregnancy for fetal thyroid development in general. NCBI
Purpose: Reduce uncertainty and support healthy future pregnancies. NCBI
Mechanism: Carrier testing and informed choices guide reproductive plans. NCBI

---

Drug treatments

Important safety note: For Bamforth–Lazarus syndrome, only one medicine directly treats the disease—levothyroxine. Other medicines may be used for symptoms (like pain control after palate surgery), but they do not treat the thyroid problem itself. Below, I provide detailed, FDA-sourced information for levothyroxine (various formulations), and then clearly mark supportive medications that may be used for associated needs. Always follow a pediatric endocrinologist’s guidance. PMC

1) Levothyroxine sodium (tablets)

Description (≈150 words): Levothyroxine is synthetic T4, the same hormone the thyroid should make. It is the standard, lifelong treatment for congenital hypothyroidism, including BAMLAZ. Babies typically start at a full replacement dose soon after diagnosis. Tablets can be crushed and mixed with a small amount of water or breast milk (not soy formula) for dosing. Doctors check T4/FT4 and TSH often (every 1–2 weeks at first, then every 1–3 months in infancy) and adjust the dose as the baby gains weight. Correct dosing prevents intellectual disability and supports normal growth. Parents should give the medicine at the same time daily and avoid giving it with iron, calcium, or soy, which reduce absorption. FDA Access Data+1
Class: Thyroid hormone (T4). FDA Access Data
Dosage/Time: Typical starting dose for CH: ~10–15 mcg/kg/day in newborns; dosing decreases per kg with age; given once daily. Exact dose individualized. FDA Access Data+1
Purpose: Replace missing hormone to normalize thyroid levels and brain/physical development. PMC
Mechanism: Provides circulating T4, which tissues convert to T3 to regulate metabolism and brain maturation. FDA Access Data
Side effects: Over-replacement can cause fast heart rate, irritability, poor weight gain; under-replacement causes lethargy and slow growth. Rare allergic reactions to inactive ingredients. FDA Access Data

2) Levothyroxine sodium (oral solution)

Description: An oral liquid (not available in all regions) helps precise dosing and avoids crushing tablets. It can improve adherence for infants. The same monitoring and spacing from iron/calcium/soy apply. FDA Access Data
Class: Thyroid hormone (T4). FDA Access Data
Dosage/Time: Weight-based once daily, as for tablets. FDA Access Data
Purpose/Mechanism/Side effects: Same as tablets. FDA Access Data

3) Levothyroxine sodium (injection; hospital use)

Description: If a baby cannot take medicine by mouth (for example, severe illness), IV levothyroxine may be used short-term in the hospital until oral dosing is possible again. FDA Access Data
Class: Thyroid hormone (T4). FDA Access Data
Dosage/Time: Given IV in controlled settings; dose adjusted relative to oral dose. FDA Access Data
Purpose/Mechanism/Side effects: Restore hormone when oral route is not possible; same benefits and risks as oral, but monitored closely. FDA Access Data

4) Liothyronine (T3) — not routine for CH

Description: Liothyronine is active T3. For congenital hypothyroidism, expert guidelines recommend levothyroxine alone in almost all cases; T3 is generally not needed in infants because the body converts T4 to T3 naturally. A specialist may rarely consider it in unusual circumstances. PMC
Class: Thyroid hormone (T3). (FDA-approved for hypothyroidism in general.) FDA Access Data
Dosage/Time: Only if a specialist decides; not standard in infants. PMC
Purpose/Mechanism/Side effects: Not standard; risks include overtreatment. PMC

5) Vitamin D (supportive, per pediatric plan)

Description: Babies commonly receive vitamin D for bone health, especially if breast-fed. This does not treat BAMLAZ, but supports normal growth. Follow pediatric dosing. PMC
Class: Nutrient supplement. PMC
Dosage/Time: Per pediatric guidance. PMC
Purpose/Mechanism/Side effects: Supports calcium metabolism; excessive dosing can harm—use only as directed. PMC

6) Post-operative pain control (e.g., acetaminophen) — supportive

Description: After palate surgery, children may receive standard pediatric pain control. These drugs do not affect thyroid status. Follow surgeon/pediatric instructions. GARD Information Center
Class: Analgesic. GARD Information Center
Dosage/Time: Per weight-based pediatric dosing. GARD Information Center
Purpose/Mechanism/Side effects: Comfort during recovery; monitor dosing carefully. GARD Information Center

(Items 7–20 intentionally omitted as “disease-specific drugs” because no other medications are evidence-based to treat the underlying condition. Using long lists of unrelated drugs would be misleading. The gold-standard, FDA-documented therapy is levothyroxine, with formulation choices and hospital IV bridging when needed. This conservative, safety-first approach follows international CH guidelines.) PMC+1

---

Dietary molecular supplements

Key caution: No supplement can replace levothyroxine in BAMLAZ, because the thyroid gland is absent or very small. Any supplement use must be coordinated with the child’s doctor, and doses must never interfere with levothyroxine absorption. PMC+1

1. Iodine (maternal, preconception/prenatal context only): Adequate iodine in pregnancy supports fetal thyroid development in general. It does not reverse FOXE1-related dysgenesis in BAMLAZ but is standard prenatal nutrition. Do not give extra iodine to the baby without medical advice. PMC
   Dose: Maternal prenatal per guidelines; infant supplementation only if prescribed. Function/Mechanism: Substrate for thyroid hormone synthesis (not effective when thyroid is absent). PMC

2. Vitamin D: Routine pediatric vitamin D supports bone health; follow pediatric guidance. Mechanism: Improves calcium absorption and bone mineralization; unrelated to fixing thyroid absence. PMC

3. Iron (only if deficient; separate from levothyroxine): Treat doctor-confirmed iron deficiency. Mechanism: Restores hemoglobin and enzymes; must be spaced several hours from levothyroxine due to absorption interference. FDA Access Data

4. Calcium (only if prescribed; separate from levothyroxine): For specific dietary needs; keep well apart from levothyroxine to avoid binding. Mechanism: Bone mineral support. FDA Access Data

5. Omega-3 (parental decision with pediatrician): General nutrition support; does not treat hypothyroidism. Mechanism: Structural fatty acids for cell membranes. PMC

6. Multivitamin (age-appropriate): May support general nutrition in picky eaters; does not affect BAMLAZ. Mechanism: Provides standard micronutrients; avoid minerals near levothyroxine dose. FDA Access Data

7. Zinc (only if deficient): For documented deficiency; spacing from thyroid medicine is required. Mechanism: Enzyme support; not thyroid replacement. FDA Access Data

8. Selenium (not routinely recommended): Selenium is involved in thyroid hormone metabolism, but not indicated to treat congenital hypothyroidism due to thyroid absence. Use only if a doctor identifies deficiency. PMC

9. Protein-rich diet (age-appropriate foods): Supports growth when solids begin; not a drug, but part of overall nutrition counseling. Mechanism: Supplies amino acids for growth. PMC

10. Fiber timing awareness: Healthy fiber intake is good, but large fiber doses may reduce levothyroxine absorption if taken together; manage timing. Mechanism: Adsorption in the gut can lower hormone absorption. FDA Access Data

---

Drugs for immunity booster, regenerative,” or “stem cell

There are no approved immune-booster drugs, regenerative medicines, or stem-cell therapies for Bamforth–Lazarus syndrome. The condition is caused by a developmental absence or malformation of the thyroid due to FOXE1 gene changes; this cannot currently be reversed with drugs or cells. Any claims to the contrary are not evidence-based. The safe, proven, lifelong treatment is levothyroxine plus standard cleft/ENT care. PMC

(Because none are approved, listing six specific “immunity” or “stem cell” drugs with doses would be misleading and unsafe for infants. Families should avoid unproven therapies and discuss any research trials with a pediatric endocrinologist.) PMC

---

Surgeries

1. Palatoplasty (cleft palate repair): A plastic surgeon closes the opening in the palate, usually in the first year of life. This improves feeding and supports normal speech as the child grows. Post-surgery, speech therapy continues to fine-tune articulation. GARD Information Center

2. Choanal atresia repair (if present): An ENT surgeon opens the blocked back-of-nose passage to improve breathing and feeding. This may be urgent in newborns with severe blockage. GARD Information Center

3. Tympanostomy tubes (ear tubes): If fluid behind the eardrum keeps returning, small tubes help drain the middle ear and protect hearing—important for speech development. GARD Information Center

4. Alveolar bone grafting (later childhood, if needed): Some children with cleft palate/lip variants need a bone graft to support tooth eruption and stabilize the upper jaw. GARD Information Center

5. Airway surgery for bifid epiglottis or related issues (if symptomatic): Rarely, airway anomalies cause significant symptoms and need tailored procedures by an ENT surgeon to secure the airway and improve swallowing. GARD Information Center

---

Preventions

1. Newborn screening and rapid treatment prevent brain injury from untreated low thyroid. Start therapy immediately after abnormal screening. PMC

2. Reliable daily dosing of levothyroxine keeps levels normal and protects learning. PMC

3. Routine lab monitoring (TSH, T4/FT4) finds dose problems early. PMC

4. Avoid drug/food interactions (iron, calcium, soy around dosing time). FDA Access Data

5. Cleft team follow-up prevents speech/hearing problems. GARD Information Center

6. ENT surveillance for airway and ear issues reduces complications. GARD Information Center

7. Genetic counseling informs carrier risks and future pregnancies. NCBI

8. Prenatal care with adequate iodine supports fetal thyroid development in general (though it cannot prevent FOXE1-based BAMLAZ). PMC

9. Medication education on correct preparation and timing improves absorption. FDA Access Data

10. Regular growth/development checks allow dose and therapy adjustments. PMC

---

When to see doctors

See your child’s pediatrician and endocrinologist urgently if you notice poor feeding, unusual sleepiness, constipation, low temperature, slow growth, or developmental delays—these can be signs that thyroid levels are too low. Also seek care for fast heartbeat, irritability, sweating, or poor weight gain, which may suggest too much hormone. ENT review is needed for noisy breathing, choking with feeds, nasal blockage, or recurrent ear infections. Keep all post-surgery appointments with the cleft team and continue speech therapy as advised. PMC+1

---

What to eat and what to avoid

1. Give levothyroxine on an empty stomach with a little water or breast milk—same time daily. FDA Access Data

2. Avoid soy formula at the same time as levothyroxine; if using soy, separate by several hours. FDA Access Data

3. Avoid iron and calcium within several hours of the dose (including fortified cereals). FDA Access Data

4. Crush tablets correctly and do not mix with large volumes or thick foods that may stick to the cup/syringe. FDA Access Data

5. Keep a consistent feeding routine so dosing and spacing are easy to remember. FDA Access Data

6. Ensure normal infant nutrition (breast milk or standard formula) unless otherwise advised; supplements only if prescribed. PMC

7. Introduce solids normally at the advised age; keep dose timing separated from high-fiber meals when possible. FDA Access Data

8. Hydration matters during recovery from surgery; offer small, frequent fluids as recommended. GARD Information Center

9. Avoid unproven “thyroid boosters.” They do not help and may be harmful. PMC

10. Ask your care team before adding any vitamin, mineral, or herbal product. PMC

---

Frequently Asked Questions (FAQs)

1) Is Bamforth–Lazarus syndrome the same as congenital hypothyroidism?
BAMLAZ is a specific cause of congenital hypothyroidism due to FOXE1 gene changes. Children have thyroid dysgenesis and often a cleft palate and distinctive hair. GARD Information Center

2) How is it diagnosed?
Through newborn screening (abnormal TSH/T4), imaging that shows absent/small thyroid, clinical exam (cleft palate), and genetic testing for FOXE1. PMC+1

3) What is the main treatment?
Daily levothyroxine (T4) by mouth started as soon as possible after birth. PMC

4) What dose does my baby need?
Dosing is weight-based and changes with age; typical newborn dose is about 10–15 mcg/kg/day, adjusted by labs and growth. Follow your endocrinologist’s exact plan. FDA Access Data

5) How often are blood tests needed?
Very often at first (e.g., every 1–2 weeks), then every 1–3 months in infancy, and less often later—whenever dose or growth changes. PMC

6) Will my child have normal development?
With early, steady treatment, most children grow and learn well. Ongoing cleft and ENT care support speech and hearing. PMC+1

7) Does food interfere with levothyroxine?
Yes. Iron, calcium, and soy can block absorption. Separate them from the dose by several hours. FDA Access Data

8) Are other thyroid drugs needed?
No, levothyroxine alone is standard for infants. T3 (liothyronine) is not routine. PMC

9) Will surgery fix the thyroid problem?
No. Surgery treats the cleft palate or airway issues, not the missing thyroid. The thyroid problem needs lifelong hormone replacement. GARD Information Center

10) Is there a cure or stem-cell therapy?
No approved regenerative or stem-cell treatments exist for BAMLAZ. Avoid unproven therapies. PMC

11) Can future pregnancies be planned safely?
Yes. Genetic counseling explains recurrence risks (autosomal recessive) and testing options. NCBI

12) What about vaccines?
Follow routine immunizations unless your doctor advises otherwise. Vaccines keep children healthy and on track for surgery and therapies. GARD Information Center

13) When is palate repair done?
Timing varies by center but is often within the first year. Your cleft team will individualize the plan. Speech therapy continues after repair. GARD Information Center

14) Does hair change with age?
Spiky/scanty hair has been reported; it may improve with time. It does not change the thyroid treatment plan. GARD Information Center

15) Where can I read more?
See Orphanet/GARD for overviews, NIH/MedGen for clinical features, and international CH guidelines for treatment details. PMC+3Orpha+3GARD Information Center+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 16, 2025.